Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Archi Indonesia Tbk (ARCI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Archi Indonesia TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Archi Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Archi Indonesia Tbk trades at Rp1,190 (market cap 30.28T, 5.3M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp164 (market cap 651.75B, 404.2K 24h volume). The key difference: Archi Indonesia Tbk is far larger — about 46.5× UBC Medical Indonesia Tbk.'s market cap, and Archi Indonesia Tbk is more actively traded (5.3M versus 404.2K). Which is the better fit depends on your goals.

ARCILABS
Market Cap
30.28T651.75B
Volume
5.3M404.2K
Lot
53.04K4.04K
Turnover
6.28B66.72M
Average Price
1,183.44165.07
Value
6.28B66.72M
Indicative Equilibrium Price
1,180165
Indicative Equilibrium Volume
3.67K300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ARCI
View details
LABS
View details

About Archi Indonesia Tbk

PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.

Read more on ARCI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS